MineBio Life Sciences Limited
MineBio Life Sciences Limited is a Shanghai-based authorized distributor and solution integrator that connects over 300 international life sciences brands with Chinese pharmaceutical, biotech, and academic customers in cell and gene therapy, stem cell, organoid, and organ-on-chip research.
- Company typePrivate
- Founded2021
- HeadquartersShanghai, China
- Headcount11–50
- GTM typeB2B
- OfferingServices
What MineBio Life Sciences Limited does
MineBio Life Sciences Limited (上海曼博生物医药科技有限公司) is a Shanghai-based authorized distributor and solution integrator founded in 2021. The company serves as the exclusive or authorized Chinese agent for more than 300 international life sciences brands, including Qkine (UK), CN Bio (UK), LifeNet Health (US), Polysciences (US), RoosterBio (US), Solallis (Japan), BioLamina (Sweden), IZON (New Zealand), Revvity (US), Axol Bioscience (UK), and Discovery Life Sciences (US). Its portfolio spans instruments (microfluidic organ-on-chip systems, bioreactors, nanoparticle analyzers, cell-free protein expression platforms, aseptic filling systems), reagents (defined culture media, recombinant cytokines, laminins, collagenases, PEI transfection reagents, cGMP-grade ancillary materials for cell and gene therapy), cells (iPSC-derived neurons and cardiomyocytes, primary hepatocytes, intestinal and respiratory in vitro models), and biospecimens (ADME reagents, PBMC/Leukopak, FFPE samples).
MineBio generates revenue by importing and reselling these third-party products to Chinese customers at margins on each transaction; pricing is quote-based and not publicly disclosed. The company sells directly through an in-house sales and technical-support team to three primary customer segments: cell and gene therapy companies (CAR-T, stem cell, gene therapy developers needing GMP-grade raw materials), pharmaceutical and drug-discovery research organizations (ADME, toxicity, DILI studies), and academic and research institutions (universities, hospitals, and research institutes conducting organoid, neuroscience, and translational research). Go-to-market is sales-led, supplemented by technical content marketing on the company website and Chinese platforms (WeChat official and video accounts, Zhihu, Bilibili, Baidu), email newsletters, and industry-conference participation such as the 12th Drug Toxicology Annual Conference in Shanghai. The head office is in Shanghai Pudong Zhangjiang, with general manager Amy Zuo (左湄) leading operations.
MineBio Life Sciences Limited firmographics
Firmographics- Name
- MineBio Life Sciences Limited
- Legal name
- 上海曼博生物医药科技有限公司
- Website
- https://mine-bio.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MineBio Life Sciences Limited is a Shanghai-based authorized distributor and solution integrator that connects over 300 international life sciences brands with Chinese pharmaceutical, biotech, and academic customers in cell and gene therapy, stem cell, organoid, and organ-on-chip research.
- Ownership category
- akta.pro rank
MineBio Life Sciences Limited industry classification
Industry- Product category
- Life Sciences Distribution
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
- akta.pro secondary industries
- Biologics & Biosimilars Distributors (HLAIAJAH), Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI)
Keywords
Where MineBio Life Sciences Limited is headquartered
LocationHeadquarters
- HQ city
- Shanghai
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
MineBio Life Sciences Limited business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Distribution of Life Sciences Products: MineBio generates revenue by serving as authorized distributor and exclusive agent for international life sciences brands, importing and selling reagents, instruments, cells, and biological samples to Chinese research institutions and pharmaceutical companies. Revenue comes from product margins and distribution fees.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
MineBio Life Sciences Limited product offering
Product offeringCore offering
MineBio Life Sciences Limited is an authorized exclusive distributor in China for more than 300 international life-sciences brands, supplying reagents, instruments, primary cells, iPSC lines, biospecimens, organ-on-chip systems, bioreactors, and transfection reagents to pharmaceutical companies, biotech firms, CDMOs, and academic research institutions. Its offering is focused on cell-and-gene therapy, stem-cell research, organoid applications, and drug-discovery workflows, complemented by local technical support, training, and regulatory/import-compliance assistance for foreign vendors.
Product overview
MineBio Life Sciences Limited is a distributor and solution provider specializing in life sciences reagents and equipment for cell & gene therapy, stem cell research, organoids, and organ-on-chip applications. The portfolio includes distributed brands covering: (1) Instruments - CN Bio microfluidic organ-chip systems, IZON nanoparticle characterization, nuclera cell-free protein expression, PBS Biotech bioreactors, Sexton filling systems; (2) Reagents - Solallis defined media, Qkine cytokines, BioLamina laminins, Nordmark collagenases, Polysciences PEI reagents, Akron cGMP materials, RoosterBio MSC media, Revvity LentiBOOST; (3) Cells - LifeNet primary hepatocytes, Axol iPSC-derived cells, Epithelix lung models, Altis intestinal models; (4) Biospecimens - DLS/Gentest/AllCells/Biospecimens products. MineBio provides these as separate brand offerings with technical support, rather than a unified platform product.
Differentiator
Problem solved
Functional benefit
Products and services
- CN Bio PhysioMimix organ-on-chip systems
Companies that use MineBio Life Sciences Limited
Customer profileSegments3 records
Ideal customer profiles2 records
MineBio Life Sciences Limited technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MineBio Life Sciences Limited partnerships and signals
Strategic signalPartnerships
20 partnerships are on record, tiered core.
- QkinecoreQkine is headquartered in Cambridge, UK, and is an ISO9001:2015 certified company specializing in bioactive recombinant proteins. MineBio serves as the authorized exclusive agent for Qkine in China, distributing Qkine's animal-free, high-purity growth factors and cytokines for stem cell research and organoid applications.
- CN BiocoreCN Bio is a UK-based company specializing in microfluidic organ-on-chip systems. MineBio is the authorized agent for CN Bio products in China, offering PhysioMimix organ-on-chip systems for drug discovery, DILI assessment, and NASH research applications.
- LifeNet HealthcoreLifeNet Health, established in 1982 and headquartered in the USA, is a non-profit organization focused on regenerative medicine and transplant solutions. MineBio is the exclusive agent for LifeNet Health in China, distributing human primary hepatocytes, Kupffer cells, hepatic stellate cells, and liver sinusoidal endothelial cells for liver research and drug metabolism studies.
- Discovery Life Sciences (DLS)coreDLS, founded in 2004 and headquartered in Alabama, USA, is a global leader in biospecimen supply and multi-omics analysis services. MineBio is the official provider of DLS products in China, covering AllCells (cell therapy raw materials), Gentest (ADME products), and Biospecimens (high-annotated biological samples).
- PolysciencescorePolysciences is a US-based manufacturer of PEI transfection reagents and specialty chemicals. MineBio is the authorized agent for Polysciences in China, distributing PEI MAX transfection reagents for viral vector production in cell and gene therapy applications.
- Revvity (LentiBOOST)coreRevvity is a global life sciences company. MineBio is the authorized agent for Revvity's LentiBOOST lentiviral transduction enhancer in China, supporting CAR-T and gene therapy vector production applications.
- Nordmark CollagenasecoreNordmark is a German company with over 30 years of experience in collagenase manufacturing. MineBio is the official provider of Nordmark Collagenase NB products in China, offering GMP-grade collagenases for tissue dissociation and cell isolation in cell therapy applications.
- RoosterBiocoreRoosterBio, headquartered in Maryland, USA, specializes in human mesenchymal stem/stromal cell (hMSC) and exosome bioprocessing solutions. MineBio is the exclusive distributor for RoosterBio in China, offering RUO and CliniControl cGMP-grade MSC and exosome culture media for CGT and regenerative medicine applications.
- SolalliscoreSolallis (Stem Design) is a Japanese company specializing in chemically defined, animal-free MSC culture media. MineBio is the authorized agent for Solallis in China, distributing MSC expansion media and EV collection media for stem cell and exosome research.
- BioLaminacoreBioLamina is a Swedish company producing human recombinant laminin proteins for stem cell culture. MineBio is the authorized agent for BioLamina in China, distributing LN521 and other laminin products for iPSC and PSC culture applications.
- Sexton BiotechnologiescoreSexton Biotechnologies is a US-based company specializing in cell processing and formulation filling systems. MineBio is the authorized agent for Sexton products in China, offering vial fillers and cryopreservation solutions for cell therapy manufacturing.
- InSpherocoreInSphero is a Swiss company providing 3D cell culture tools for drug discovery. MineBio is the authorized agent for InSphero in China, distributing Gri3D hydrogel microwell plates for standardized organoid culture.
- Altis Biosystems (RepliGut)coreAltis Biosystems, founded in 2015 and headquartered in North Carolina, USA, specializes in human intestinal in vitro models. MineBio is the authorized agent for Altis products in China, distributing RepliGut planar human intestinal models for ADME research.
- EpitheliXcoreEpitheliX, founded in 2006 and headquartered in Geneva, Switzerland, specializes in human respiratory tissue engineering and in vitro models. MineBio is the authorized agent for EpitheliX in China, distributing MucilAir, SmallAir, and AlveolAir respiratory models for drug discovery and toxicity assessment.
- Axol BiosciencecoreAxol Bioscience, founded in 2013 and headquartered in Cambridge, UK, specializes in iPSC-derived neurons and cardiomyocytes. MineBio is the authorized agent for Axol products in China, distributingaxoCells iPSC-derived cells for neuroscience and cardiovascular research.
- IZONcoreIZON is a New Zealand-based company specializing in extracellular vesicle and nanoparticle isolation and characterization. MineBio is the authorized agent for IZON products in China, distributing qEV isolation columns, AFC fraction collectors, and nanoparticle analyzers (Exoid, Pulsoid) for exosome research.
- NETRIcoreNETRI is a French company developing neural organ-on-chip systems. MineBio is the authorized agent for NETRI products in China, distributing neural chips for neuromuscular junction (NMJ) modeling and neurodegenerative disease research.
- PBS BiotechcorePBS Biotech is a US-based company specializing in vertical-wheel single-use bioreactors. MineBio is the authorized agent for PBS Biotech in China, offering bioreactors for scalable MSC and cell therapy manufacturing.
- NucleracoreNuclera is a UK-based company providing cell-free protein expression screening systems. MineBio is the authorized agent for Nuclera products in China, distributing eProtein Discovery systems for rapid protein expression and screening.
- BeonchipcoreBeonchip is a Spanish company developing flexible organ-on-chip systems. MineBio is the authorized agent for Beonchip products in China, distributing flexible organ-on-chip devices for various biomedical research applications.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
MineBio Life Sciences Limited competitors and assessment
Company assessmentBroad incumbents
- Avantor (VWR): Global distributor of life sciences products, equipment, and consumables to research and pharma customers with significant Chinese presence. Comparable to MineBio in the distribution of third-party life sciences products to research and biotech customers, but with broader catalog and global scale.
- GenScript Biotech: China-based global life sciences group with reagent manufacturing, gene synthesis, and CDMO services. Comparable to MineBio as a Chinese-headquartered life sciences product and services provider serving cell therapy and drug discovery customers, but operates at significantly larger scale and with proprietary technology.
- Bio-Techne: US-based global life sciences company with reagent, protein, and cell therapy product lines (R&D Systems, Tocris, ProteinSimple). Comparable to MineBio in selling CGT-related reagents into research and pharma markets, with established China distribution.
- Miltenyi Biotec: Germany-based global life sciences company providing cell separation, flow cytometry, and cell therapy manufacturing solutions. Comparable to MineBio given overlapping focus on cell therapy reagent and instrument categories and direct presence in Chinese research and CGT markets.
- WuXi AppTec: China-headquartered global CRO/CDMO with a life sciences products and services segment. Comparable to MineBio in serving Chinese biotech and pharma customers with research and CGT-related products, but at vastly larger scale and with integrated service offerings.
- Thermo Fisher Scientific: Global life sciences incumbent with extensive China operations distributing reagents, instruments, and consumables directly to research and pharma customers. Comparable to MineBio in overlapping product categories (cell culture, primary cells, reagents) and customer base, but at vastly larger scale and with direct (not agency) distribution.
- Cytiva: Global life sciences tools provider (formerly GE Healthcare Life Sciences) offering bioreactors, cell therapy manufacturing solutions, and bioprocessing consumables. Comparable to MineBio given brands like PBS Biotech (in MineBio's portfolio) compete with Cytiva's Xuri bioreactor line in the CGT bioprocessing space.
Direct peers
- Taron Solutions: Chinese distributor of imported life sciences research reagents and instruments for cell biology and drug discovery. Most direct peer to MineBio in business model — Chinese-authorized distributor for international life sciences brands serving Chinese research institutions.
- Sino Biological: China-based manufacturer and distributor of recombinant proteins, antibodies, and reagents for biopharma and research. Comparable to MineBio in serving Chinese and global life sciences customers with research and CGT-grade reagents, with overlapping product categories like cytokines and growth factors.
- STEMCELL Technologies: Canada-based specialty life sciences company specializing in cell culture media, reagents, and instruments for stem cell and cell therapy research. Comparable to MineBio given overlapping product categories (MSC media, cytokines, cell processing tools) and similar customer base of CGT and academic researchers.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
MineBio Life Sciences Limited social profiles
Digital presenceMineBio Life Sciences Limited financial estimates
Financial estimateRevenue estimate
Valuation estimate
MineBio Life Sciences Limited leadership team
Management profileNumber of profiles
Profiles1 record
MineBio Life Sciences Limited funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MineBio Life Sciences Limited M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MineBio Life Sciences Limited
What does MineBio Life Sciences Limited do?
MineBio Life Sciences Limited is an authorized exclusive distributor in China for more than 300 international life-sciences brands, supplying reagents, instruments, primary cells, iPSC lines, biospecimens, organ-on-chip systems, bioreactors, and transfection reagents to pharmaceutical companies, biotech firms, CDMOs, and academic research institutions. Its offering is focused on cell-and-gene therapy, stem-cell research, organoid applications, and drug-discovery workflows, complemented by local technical support, training, and regulatory/import-compliance assistance for foreign vendors.
Is MineBio Life Sciences Limited a public or private company?
MineBio Life Sciences Limited is a private company. It is classified as unknown and is currently operating.
When was MineBio Life Sciences Limited founded?
MineBio Life Sciences Limited was founded in 2021. It employs 11 to 50 people.
Where is MineBio Life Sciences Limited based?
MineBio Life Sciences Limited is headquartered in Shanghai, China, in the Asia region.
How does MineBio Life Sciences Limited make money?
One revenue line is on record: distribution of Life Sciences Products.
Who are MineBio Life Sciences Limited's main competitors?
Broad incumbents on record are Avantor (VWR), GenScript Biotech, Bio-Techne, Miltenyi Biotec, WuXi AppTec, Thermo Fisher Scientific and Cytiva. Direct peers are Taron Solutions, Sino Biological and STEMCELL Technologies.
Does MineBio Life Sciences Limited have an API?
No public API is recorded for MineBio Life Sciences Limited.
What industry is MineBio Life Sciences Limited in?
MineBio Life Sciences Limited's product category is Life Sciences Distribution. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of HLAIAJAH, Biologics & Biosimilars Distributors. Its NAICS code is 3391 and its SIC code is 2836.